Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Periampullary cancers: are there differences?

J M Sarmiento1, D M Nagomey, M G Sarr

  • 1Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.

The Surgical Clinics of North America
|July 19, 2001
PubMed
Summary

Outcomes for periampullary cancers after resection differ significantly. Pancreatic cancer has the poorest survival, while ampullary and duodenal cancers offer the best prognosis following pancreaticoduodenectomy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Campylobacter hepaticus as an indicator organism to assess biosecurity on commercial egg farms.

Poultry science·2026
Same author

Comparative performance of air sampling methods in a broiler house: implications for use and recovery of bacteria.

Poultry science·2026
Same author

The future of scientific publishing.

The British journal of surgery·2019
Same author

Evaluation of a sprinkler cooling system on inhalable dust and ammonia concentrations in broiler chicken production.

Journal of occupational and environmental hygiene·2016
Same author

Technical considerations in performing posterior component separation with transverse abdominis muscle release.

Hernia : the journal of hernias and abdominal wall surgery·2016
Same author

Reply to comment to Long-term outcomes (>5 years follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection: Negro P, D'Amore L, Ceci F, Gossetti F (DOI 10.1007/s10029-015-1406-1).

Hernia : the journal of hernias and abdominal wall surgery·2015

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Oncology

Background:

  • Periampullary cancers encompass tumors originating from the ampulla of Vater, duodenum, bile duct, and pancreas.
  • These diverse tumors present unique challenges in diagnosis and treatment, impacting patient outcomes.
  • Pancreaticoduodenectomy (Whipple procedure) is the standard surgical approach for resectable periampullary malignancies.

Purpose of the Study:

  • To analyze and compare survival outcomes for different types of periampullary cancers following pancreaticoduodenectomy.
  • To identify factors influencing survival, including tumor origin, stage, and local invasion.
  • To evaluate the current surgical approach and explore future therapeutic strategies for improving patient survival.

Main Methods:

  • Systematic review of existing clinical data and published literature on periampullary cancers.

Related Experiment Videos

  • Comparative analysis of overall survival rates based on tumor histology and location (ampullary, duodenal, bile duct, pancreatic).
  • Evaluation of prognostic factors such as tumor stage, lymph node status, and pancreatic invasion.

    • Main Results:

    • Overall survival after pancreaticoduodenectomy is highest for ampullary and duodenal cancers, intermediate for bile duct cancers, and lowest for pancreatic cancers.
    • Nonpancreatic periampullary cancers demonstrate better survival than pancreatic cancers, even at similar tumor stages.
    • Invasion into the pancreas by nonpancreatic tumors is a significant negative prognostic factor.
    • Tumor biology, rather than anatomical or histological differences, is likely the primary driver of survival disparities.

    Conclusions:

    • Periampullary cancers exhibit variable prognoses after resection, with pancreatic cancer having the poorest outcomes.
    • Pancreaticoduodenectomy remains the gold standard for resectable periampullary cancers.
    • Future survival improvements are anticipated through advancements in neoadjuvant and adjuvant therapies rather than surgical modifications.